Related references
Note: Only part of the references are listed.HER2 status in gastric cancers: a retrospective analysis from four Chinese representative clinical centers and assessment of its prognostic significance
W. Q. Sheng et al.
ANNALS OF ONCOLOGY (2013)
HER2 expression and its clinicopathological features in resectable gastric cancer
Yoshiki Kataoka et al.
GASTRIC CANCER (2013)
Prognosis of metastatic gastric and gastroesophageal junction cancer by HER2 status: a European and USA International collaborative analysis
Y. Y. Janjigian et al.
ANNALS OF ONCOLOGY (2012)
Trends in mortality from cancers of the breast, colon, prostate, esophagus, and stomach in East Asia: role of nutrition transition
Jianjun Zhang et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2012)
Comprehensive analysis of HER2 expression and gene amplification in gastric cancers using immunohistochemistry and in situ hybridization: which scoring system should we use?
Young Soo Park et al.
HUMAN PATHOLOGY (2012)
HER2 testing in gastric cancer: a practical approach
Josef Rueschoff et al.
MODERN PATHOLOGY (2012)
Gastric cancer incidence and mortality in Zhuanghe, China, between 2005 and 2010
Jing-Jing Jing et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Dating the Rise of Esophageal Adenocarcinoma: Analysis of Connecticut Tumor Registry Data, 1940-2007
Julian A. Abrams et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Pertuzumab in Combination with Trastuzumab Shows Significantly Enhanced Antitumor Activity in HER2-Positive Human Gastric Cancer Xenograft Models
Yoriko Yamashita-Kashima et al.
CLINICAL CANCER RESEARCH (2011)
Japanese classification of gastric carcinoma: 3rd English edition
GASTRIC CANCER (2011)
Hybridization for human epidermal growth factor receptor 2 testing in gastric carcinoma: a comparison of fluorescence in-situ hybridization with a novel fully automated dual-colour silver in-situ hybridization method
Elena Garcia-Garcia et al.
HISTOPATHOLOGY (2011)
Trend in gastric cancer: 35 years of surgical experience in Japan
Keishi Yamashita et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2010)
The impact of pre-analytical processing on staining quality for H&E, dual hapten, dual color in situ hybridization and fluorescent in situ hybridization assays
Andrea Babic et al.
METHODS (2010)
HER2 diagnostics in gastric cancer-guideline validation and development of standardized immunohistochemical testing
Josef Rueschoff et al.
VIRCHOWS ARCHIV (2010)
Assessment of a HER2 scoring system for gastric cancer:: results from a validation study
M. Hofmann et al.
HISTOPATHOLOGY (2008)
High inter-observer agreement in immunohistochemical evaluation of HER-2/neu expression in breast cancer:: A multicentre GEFPICS study
Magali Lacroix-Triki et al.
EUROPEAN JOURNAL OF CANCER (2006)
Disparities in the classification of esophageal and cardia adenocarcinomas and their influence on reported incidence rates
M Lindblad et al.
ANNALS OF SURGERY (2006)
Incidence and mortality of gastric cancer in China
Ling Yang
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Share Paper
